Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.
Helen and Robert Appel Alzheimer's Disease Institute, Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.
Nat Commun. 2022 Apr 12;13(1):1969. doi: 10.1038/s41467-022-29552-6.
Activation of microglia is a prominent pathological feature in tauopathies, including Alzheimer's disease. How microglia activation contributes to tau toxicity remains largely unknown. Here we show that nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling, activated by tau, drives microglial-mediated tau propagation and toxicity. Constitutive activation of microglial NF-κB exacerbated, while inactivation diminished, tau seeding and spreading in young PS19 mice. Inhibition of NF-κB activation enhanced the retention while reduced the release of internalized pathogenic tau fibrils from primary microglia and rescued microglial autophagy deficits. Inhibition of microglial NF-κB in aged PS19 mice rescued tau-mediated learning and memory deficits, restored overall transcriptomic changes while increasing neuronal tau inclusions. Single cell RNA-seq revealed that tau-associated disease states in microglia were diminished by NF-κB inactivation and further transformed by constitutive NF-κB activation. Our study establishes a role for microglial NF-κB signaling in mediating tau spreading and toxicity in tauopathy.
小胶质细胞的激活是包括阿尔茨海默病在内的 tau 病的一个突出的病理特征。小胶质细胞的激活如何导致 tau 毒性仍然很大程度上不清楚。在这里,我们表明,tau 激活的核因子 kappa 轻链增强子的 B 细胞(NF-κB)信号转导驱动小胶质细胞介导的 tau 传播和毒性。小胶质细胞 NF-κB 的组成性激活加剧了年轻 PS19 小鼠中的 tau 播种和扩散,而失活则减弱了 tau 播种和扩散。NF-κB 激活的抑制增强了内吞致病性 tau 原纤维的保留,同时减少了其释放,从而挽救了小胶质细胞自噬缺陷。在老年 PS19 小鼠中抑制小胶质细胞 NF-κB 可挽救 tau 介导的学习和记忆缺陷,恢复整体转录组变化,同时增加神经元 tau 包含物。单细胞 RNA-seq 显示,NF-κB 失活可减轻小胶质细胞中与 tau 相关的疾病状态,并通过组成性 NF-κB 激活进一步转化。我们的研究确立了小胶质细胞 NF-κB 信号在介导 tau 病中的 tau 传播和毒性中的作用。
Nat Commun. 2022-4-12
J Clin Invest. 2024-1-16
Alzheimers Dement. 2024-7
Front Aging Neurosci. 2025-7-11
Nat Commun. 2020-1-31
Nat Neurosci. 2019-12-23
Nature. 2019-11-20
Front Pharmacol. 2019-9-12
Front Immunol. 2019-5-9